Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Podichetty JT"'
Autor:
Morales JF; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA., Klose M; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA., Hoffert Y; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA., Podichetty JT; Critical Path Institute, Tucson, Arizona, USA., Burton J; Critical Path Institute, Tucson, Arizona, USA., Schmidt S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA., Romero K; Critical Path Institute, Tucson, Arizona, USA., O'Doherty I; Critical Path Institute, Tucson, Arizona, USA., Martin F; Breakthrough T1D, New York, New York, USA., Campbell-Thompson M; Department of Pathology, Immunology and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, USA., Haller MJ; Department of Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, USA., Atkinson MA; Department of Pathology, Immunology and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, USA.; Department of Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Gainesville, Florida, USA., Kim S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Orlando, Florida, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Aug; Vol. 13 (8), pp. 1309-1316. Date of Electronic Publication: 2024 Jul 03.
Autor:
Anderson W; Critical Path Institute, Tucson, Arizona, USA., Braun I; Critical Path Institute, Tucson, Arizona, USA., Bhatnagar R; Critical Path Institute, Tucson, Arizona, USA., Romero K; Critical Path Institute, Tucson, Arizona, USA., Walls R; Critical Path Institute, Tucson, Arizona, USA., Schito M; Critical Path Institute, Tucson, Arizona, USA., Podichetty JT; Critical Path Institute, Tucson, Arizona, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Jul; Vol. 116 (1), pp. 38-41. Date of Electronic Publication: 2024 Apr 22.
Autor:
Podichetty JT; Critical Path Institute, Tucson, Arizona, USA., Sardar S; Critical Path Institute, Tucson, Arizona, USA., Henscheid N; Critical Path Institute, Tucson, Arizona, USA., Lee GV; Critical Path Institute, Tucson, Arizona, USA., Abrams JR; Critical Path Institute, Tucson, Arizona, USA., Anderson W; Critical Path Institute, Tucson, Arizona, USA., Ma SC; Critical Path Institute, Tucson, Arizona, USA., Romero K; Critical Path Institute, Tucson, Arizona, USA.
Publikováno v:
Clinical and translational science [Clin Transl Sci] 2024 Jun; Vol. 17 (6), pp. e13851.
Autor:
Shahin MH; Clinical Pharmacology and Bioanalytics, Pfizer Inc., Groton, Connecticut, USA., Barth A; Clinical Pharmacology and Bioanalytics, Pfizer Inc., Groton, Connecticut, USA., Podichetty JT; Critical Path Institute, Tucson, Arizona, USA., Liu Q; Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Goyal N; Clinical Pharmacology and Pharmacometrics, Janssen Research and Development, LLC., Spring House, Pennsylvania, USA., Jin JY; Department of Clinical Pharmacology, Genentech, South San Francisco, California, USA., Ouellet D; Clinical Pharmacology and Pharmacometrics, Janssen Research and Development, LLC., Spring House, Pennsylvania, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2024 Apr; Vol. 115 (4), pp. 698-709. Date of Electronic Publication: 2023 Nov 13.
Autor:
Klein A; Critical Path Institute, Tucson, Arizona, USA. Electronic address: aklein@c-path.org., Loupy A; Université de Paris, Cité, Institut national de la santé et de la recherche médicale, U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France., Stegall M; Department of Surgery, Mayo Clinic, Rochester, Minnesota, USA., Helanterä I; Department of Transplantation and Liver Surgery, Helsinki University Hospital, Helsinki, Finland., Kosinski L; Critical Path Institute, Tucson, Arizona, USA., Frey E; Critical Path Institute, Tucson, Arizona, USA., Aubert O; Université de Paris, Cité, Institut national de la santé et de la recherche médicale, U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France., Divard G; Université de Paris, Cité, Institut national de la santé et de la recherche médicale, U970, PARCC, Paris Translational Research Centre for Organ Transplantation, Paris, France., Newell K; Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, Georgia, USA., Meier-Kriesche HU; Veloxis Pharmaceuticals, Cary, North Carolina, USA., Mannon RB; Department of Medicine, Division of Nephrology, University of Nebraska Medical Center, Omaha, Nebraska, USA., Dumortier T; Pharmacometrics, Novartis, Basel, Switzerland., Aggarwal V; Critical Path Institute, Tucson, Arizona, USA., Podichetty JT; Critical Path Institute, Tucson, Arizona, USA., O'Doherty I; Critical Path Institute, Tucson, Arizona, USA., Gaber AO; Department of Surgery, Houston Methodist Hospital, Houston, Texas, USA, and Weill Cornell Medicine, New York, New York, USA., Fitzsimmons WE; Critical Path Institute, Tucson, Arizona, USA.
Publikováno v:
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons [Am J Transplant] 2023 Oct; Vol. 23 (10), pp. 1496-1506. Date of Electronic Publication: 2023 Sep 18.
Autor:
Klein A; Critical Path Institute, Tucson, AZ, United States., Loupy A; Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France., Stegall M; Department of Surgery, Mayo Clinic, Rochester, Rochester, MN, United States., Helanterä I; Department of Transplantation and Liver Surgery, Helsinki University Central Hospital, Helsinki, Finland., Kosinski L; Critical Path Institute, Tucson, AZ, United States., Frey E; Critical Path Institute, Tucson, AZ, United States., Aubert O; Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France., Divard G; Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France., Newell K; Division of Transplantation, Department of Surgery, Emory University School of Medicine, Atlanta, GA, United States., Meier-Kriesche HU; Veloxis Pharmaceuticals, Cary, NC, United States., Mannon R; Division of Nephrology, Department of Internal Medicine, College of Medicine, University of Nebraska Medical Center, Omaha, NE, United States., Dumortier T; Pharmacometrics, Novartis, Basel, Switzerland., Aggarwal V; Critical Path Institute, Tucson, AZ, United States., Podichetty JT; Critical Path Institute, Tucson, AZ, United States., O'Doherty I; Critical Path Institute, Tucson, AZ, United States., Gaber AO; Department of Surgery, Houston Methodist Hospital, Houston, TX, United States., Fitzsimmons WE; Critical Path Institute, Tucson, AZ, United States.
Publikováno v:
Transplant international : official journal of the European Society for Organ Transplantation [Transpl Int] 2023 Sep 25; Vol. 36, pp. 11951. Date of Electronic Publication: 2023 Sep 25 (Print Publication: 2023).
Autor:
Pauley M; Critical Path Institute, Tucson, Arizona, USA., Henscheid N; Critical Path Institute, Tucson, Arizona, USA., David SE; Critical Path Institute, Tucson, Arizona, USA., Karpen SR; Critical Path Institute, Tucson, Arizona, USA., Romero K; Critical Path Institute, Tucson, Arizona, USA., Podichetty JT; Critical Path Institute, Tucson, Arizona, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2023 Sep; Vol. 114 (3), pp. 704-711. Date of Electronic Publication: 2023 Jun 30.
Autor:
Morales JF; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Florida, Orlando, USA., Muse R; Critical Path Institute, Arizona, Tucson, USA., Podichetty JT; Critical Path Institute, Arizona, Tucson, USA., Burton J; Critical Path Institute, Arizona, Tucson, USA., David S; Critical Path Institute, Arizona, Tucson, USA., Lang P; Critical Path Institute, Arizona, Tucson, USA., Schmidt S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Florida, Orlando, USA., Romero K; Critical Path Institute, Arizona, Tucson, USA., O'Doherty I; Critical Path Institute, Arizona, Tucson, USA., Martin F; JDRF, New York, New York, USA., Campbell-Thompson M; Department of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Florida, Gainesville, USA., Haller MJ; Department of Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Florida, Gainesville, USA., Atkinson MA; Department of Pathology, Immunology, and Laboratory Medicine, Diabetes Institute, College of Medicine, University of Florida, Florida, Gainesville, USA.; Department of Pediatrics, Diabetes Institute, College of Medicine, University of Florida, Florida, Gainesville, USA., Kim S; Department of Pharmaceutics, Center for Pharmacometrics and Systems Pharmacology, College of Pharmacy, University of Florida, Florida, Orlando, USA.
Publikováno v:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2023 Jul; Vol. 12 (7), pp. 1016-1028. Date of Electronic Publication: 2023 May 03.
Autor:
Bhatnagar R; Data Science, Data Collaboration Center, Critical Path Institute, Tucson, Arizona, USA., Sardar S; Quantitative Medicine, Critical Path Institute, Tucson, Arizona, USA., Beheshti M; Quantitative Medicine, Critical Path Institute, Tucson, Arizona, USA., Podichetty JT; Quantitative Medicine, Critical Path Institute, Tucson, Arizona, USA.
Publikováno v:
JAMIA open [JAMIA Open] 2022 Jun 11; Vol. 5 (2), pp. ooac043. Date of Electronic Publication: 2022 Jun 11 (Print Publication: 2022).
Autor:
Podichetty JT; Critical Path Institute, Tucson, Arizona, USA., Lang P; Critical Path Institute, Tucson, Arizona, USA., O'Doherty IM; Critical Path Institute, Tucson, Arizona, USA., David SE; Critical Path Institute, Tucson, Arizona, USA., Muse RN; Critical Path Institute, Tucson, Arizona, USA., Karpen SR; Critical Path Institute, Tucson, Arizona, USA., Song LS; Critical Path Institute, Tucson, Arizona, USA., Romero K; Critical Path Institute, Tucson, Arizona, USA., Burton JK; Critical Path Institute, Tucson, Arizona, USA.
Publikováno v:
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2022 May; Vol. 111 (5), pp. 1133-1141. Date of Electronic Publication: 2022 Mar 11.